Ac-RLIEDICLPRWGCLWEDD-NH2

Ref. 3D-PP43386

Informations sur le produit

• Nom: Ac-RLIEDICLPRWGCLWEDD-NH2
• Synonymes: Ac-Arg-Leu-Ile-Glu-Asp-Ile-Cys-Leu-Pro-Arg-Trp-Gly-Cys-Leu-Trp-Glu-Asp-Asp-amide

Description

Peptide Ac-RLIEDICLPRWGCLWEDD-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-RLIEDICLPRWGCLWEDD-NH2 include the following: Improving the circulation time and renal therapeutic potency of extracellular vesicles using an endogenous ligand binding strategy S Liu, K Lv, Y Wang, P Lou, P Zhou, C Wang - Journal of Controlled , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365922007611 Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonist M Gomez-Soler , EJ Olson, ER de la Torre - European Journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523423008437 Potency and pharmacokinetic enhancement of D-peptide HIV-1 entry inhibitors JS Redman - 2012 - search.proquest.comhttps://search.proquest.com/openview/b2d17fc89f896dc342107982ad978ac0/1?pq-origsite=gscholar&cbl=18750 Development of compstatin derivative-albumin binding peptide chimeras for prolonged plasma half-life H Qu, P Magotti, D Ricklin , JD Lambris - The 21st American Peptide , 2009 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=8bb1965ae6f5de765c1512b6df8b68250b5423c0 Drug delivery strategies for cathepsin inhibitors in joint diseases D Wang , D Brömme - Expert Opinion on Drug Delivery, 2005 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/17425247.2.6.1015

• Marque: Biosynth